Memorial Sloan Kettering Cancer Center: Lymphoma, Large-Cell, Immunoblastic trials
The registry lists 21 Lymphoma, Large-Cell, Immunoblastic studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 7Phase 2 10Phase 3 3No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00425802Phase 2Results posted
- Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerCompletedNCT00027560Phase 2Results posted
- Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's LymphomaCompletedNCT00059904Phase 2
- Pyroxamide in Treating Patients With Advanced CancerCompletedNCT00042900Phase 1
- ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00016172Phase 1
- Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell TransplantationCompletedNCT00014482Not applicable
- Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer TreatmentCompletedNCT00008359Phase 3
- PS-341 in Treating Patients With Hematologic CancerCompletedNCT00006098Phase 1
- St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerCompletedNCT00005805Phase 3
- Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00005634Phase 1
- Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell LymphomaCompletedNCT00005631Phase 2
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's LymphomaCompletedNCT00005040Phase 2
- Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerCompletedNCT00004061Phase 2
- Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomasCompletedNCT00004057Phase 1
- Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003956Phase 1
- Arsenic Trioxide in Treating Patients With Advanced Hematologic CancerCompletedNCT00003395Phase 1
- Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By ChemotherapyCompletedNCT00003341Phase 3
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's LymphomaCompletedNCT00002982Phase 2
- Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00002697Phase 2
- Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeCompletedNCT00002502Phase 2
- Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's LymphomaCompletedNCT00002471Phase 2